Abstract Number: 1409 • 2014 ACR/ARHP Annual Meeting
Pregnancy Outcomes after Exposure to Certolizumab Pegol: Updated Results from Safety Surveillance
Background/Purpose Certolizumab pegol (CZP) is a PEGylated Fc-free anti-TNF approved for the treatment of RA, CD, psoriatic arthritis (PsA) and ankylosing spondylitis (AS). The objective…Abstract Number: 1408 • 2014 ACR/ARHP Annual Meeting
Inflammatory Biomarkers, Sleep Quantity and Sleep Quality in Rheumatoid Arthritis
Background/Purpose: Sleep problems affect over 60% of rheumatoid arthritis (RA) patients. However, little is known about the association between sleep problems and inflammatory pathways in…Abstract Number: 1407 • 2014 ACR/ARHP Annual Meeting
Low HAQ and Pain Predict Patient Perceived Remission in Rheumatoid Arthritis Patients Receiving MTX or Anti-TNF-Alpha Treatment
Background/Purpose The induction of remission is the primary target of RA therapy. Failing to achieve the patient global estimate of disease activity criterion (PGAAbstract Number: 1405 • 2014 ACR/ARHP Annual Meeting
Five-Year Changes in Myocardial Structure and Function in Patients with Rheumatoid Arthritis
Background/Purpose: Patients with rheumatoid arthritis (RA) suffer an increased risk of heart failure not explained by traditional cardiovascular risk factors. Previously, we have shown…Abstract Number: 1406 • 2014 ACR/ARHP Annual Meeting
Comorbidity in Rheumatoid Arthritis. It Is Feasible to Record Concomitant Medical Conditions and Multi-Morbidity in Observational Research Studies. Can This be Extended to Routine Clinical Settings?
Background/Purpose Comorbidity in RA can delay diagnosis and influence treatment decisions. It is known to affect RA outcomes, and can confound data analysis. Most RA…Abstract Number: 1404 • 2014 ACR/ARHP Annual Meeting
Presence and Significance of Anti-CCP Antibody in Patients with Interstitial Lung Disease with and without Clinically Apparent Rheumatoid Arthritis
Background/Purpose: Interstitial lung disease (ILD) can be idiopathic or associated with underlying etiologies including rheumatoid arthritis (RA). The purpose of this study is to determine…Abstract Number: 1403 • 2014 ACR/ARHP Annual Meeting
Psychosocial Impact of Rheumatoid Arthritis Patients on Their Family Members
Background/Purpose Rheumatoid arthritis (RA) is a chronic inflammatory arthritis that can cause pain and functional disability, and RA patients have a higher risk of psychiatric…Abstract Number: 1402 • 2014 ACR/ARHP Annual Meeting
Parameters of Periodontitis Correlate with Anti-Citrullinated Protein Antibodies and P. Gingivalis Antibody Titers in Patients with Early or Chronic Rheumatoid Arthritis
Background/Purpose Emerging evidence suggests that periodontitis and periodontal pathogens, such as Porphyromonas gingivalis (Pg), may be an environmental trigger for rheumatoid arthritis (RA). We found…Abstract Number: 1398 • 2014 ACR/ARHP Annual Meeting
Spontaneous Regression of Methotrexate (MTX)-Related Lymphoproliferative Disorder Correlates with Lymphocyte Restoration after MTX Withdrawal
2013 > Five patients were given chemotherapy after the diagnosis of MTX-LPD, so we analyzed the remaining 27 patients in this study. Baseline characteristics of…Abstract Number: 1397 • 2014 ACR/ARHP Annual Meeting
Impact of Corticosteroid Use on Remission Sustainability and Infection Rates Among Rheumatoid Arthritis Patients in Remission While on Infliximab: Treatment Implications Based on a Real-World Canadian Population
Background/Purpose The Canadian Rheumatology Association1 recommends that addition of corticosteroids (CS) should be considered only for the shortest period possible in rheumatoid arthritis (RA) patients…Abstract Number: 1396 • 2014 ACR/ARHP Annual Meeting
Assessment of Pulmonary Function in Rheumatoid Arthritis Patients Attending Rheumatology Clinics in Nairobi,Kenya
Background/Purpose: Pulmonary involvement is frequent and among the most severe extra-articular manifestations of Rheumatoid arthritis (RA) ranking as the second cause of mortality in this…Abstract Number: 1395 • 2014 ACR/ARHP Annual Meeting
Disease Activity Is Associated with Insulin Resistance in Early Rheumatoid Arthritis
Background/Purpose: Rheumatoid arthritis (RA) is a systemic disease that manifests mainly with articular symptoms, but the main cause of death is cardiovascular disease (CVD). Chronic…Abstract Number: 1394 • 2014 ACR/ARHP Annual Meeting
Low Vitamin D Level Is Not Associated with Increased Risk of Cardiovascular Disease in Rheumatoid Arthritis Patients
Background/Purpose: Cardiovascular disease (CVD) is the leading cause of death in patients with Rheumatoid Arthritis (RA). Vitamin D deficiency is prevalent in RA and it…Abstract Number: 1393 • 2014 ACR/ARHP Annual Meeting
Periodontal Disease and Its Impact on Structural Joint Damage in a Rheumatoid Arthritis Peruvian Population
Background/Purpose Periodontal disease (PD) or periodontitis is currently considered an epigenetic determinant of both occurrence and severity of Rheumatoid Arthritis (RA). Common pathophysiological mechanisms like…Abstract Number: 1392 • 2014 ACR/ARHP Annual Meeting
Predictors of Long-Term Changes in Body Mass Index in Rheumatoid Arthritis
Background/Purpose Low body mass index (BMI) is a risk factor for poor long-term outcomes in rheumatoid arthritis (RA). Low BMI in RA has been speculated…
ACR Meeting Abstracts